Skip to content

Study on Formulation and Clinical Verification of Standardized Protocol for Transcutaneous Electrical Acupoint Stimulation in Promoting Postoperative Gastrointestinal Function Recovery After Peritoneal Cancer Surgery

Study on Formulation and Clinical Verification of Standardized Protocol for Transcutaneous Electrical Acupoint Stimulation in Promoting Postoperative Gastrointestinal Function Recovery After Peritoneal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001738
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal carcinoma

Interventions

TEAS Intervention Group:Transcutaneous Electrical Acupoint Stimulation (TEAS)
Sham Stimulation Control Group:Low-current sham stimulation

Sponsors

Beijing Shijitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with primary peritoneal carcinoma or peritoneal metastasis confirmed by imaging combined with pathological or cytological examination, who are planned to receive CRS+HIPEC; (2) Age ranging from 18 to 75 years old; (3) Body mass index (BMI): 18–31 kg/m²; (4) American Society of Anesthesiologists (ASA) physical status classification Grade I–III; (5) Voluntarily participate after full informed consent and sign the written informed consent form.

Exclusion criteria

Exclusion criteria: (1) Scarring, skin infection or sensory disturbance on the skin surrounding target acupoints (Zusanli, Shangjuxu, Hegu, Neiguan); (2) Pre-existing peripheral nerve injury or prior spinal surgery history; (3) Implanted electronic devices such as cardiac pacemakers; (4) Preoperative intestinal obstruction or severe gastrointestinal motility disorders; (5) Long-term preoperative use of analgesic medications; (6) Confirmed psychiatric or neurological disorders; (7) Requirement for intraoperative colostomy; (8) Cognitive dysfunction precluding cooperation with treatment and outcome assessments.

Design outcomes

Primary

MeasureTime frame
Time to first postoperative flatus;Time to first postoperative defecation;

Secondary

MeasureTime frame
Time to recovery of bowel sounds;Time to first oral feeding;Severity of nausea and vomiting;Length of hospital stay;Hospitalization cost;Postoperative complications;Karnofsky Performance Status (KPS) score ;

Countries

China

Contacts

Public ContactYang Tao

Beijing Shijitan Hospital, Capital Medical University

yangtao@bjsjth.cn18810255700

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026